Clinique Ovo
Montreal, Quebec, H4P 2S4, Canada
NCT Number: NCT06502665
Studies reported various risk factors for inadequate ovulation induction such as body mass index, low ovarian reserve, low baseline FSH and LH, and previous use of contraception or agonist.
The flexibility to use human chorionic gonadotropin (hCG) or gonadotropin-releasing hormone agonist (GnRHa) in ovulation induction for antagonist protocol or progestin primed ovarian stimulation (PPOS) is an advantage helping fertility doctors to decrease the risk of ovarian hyperstimulation syndrome. However, luteinizing hormone (LH) levels <15UI/L and progesterone ≤11.13nmol/L eight to twelve hours post GnRHa trigger were highly correlated to failed oocyte pickup (FOP).
Rescue hCG have been found to increase favorable outcomes in patients with FOP. The presence of false FOP could be due pharmaceutical reasons and human error. Genuine FOP could be due to intrinsic ovarian pathology.
The FOP is defined as the absence of oocytes after ovarian stimulation and follicular aspiration. It is an uncomfortable situation for the patient and medical team to deal with due to the apparent expectations of favorable results.
Ovulation induction could be via GnRHa, HCG, or both in antagonist protocol and PPOS protocol. Long or short agonist protocol could be triggered only via HCG.
Looking for future studies?
Notify MeFemale
Observational
Montreal, Quebec, H4P 2S4, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
IVF success is defined by the number of retrieved oocytes. Identifying women at risk of failed oocyte pick-up at the first oocyte pick-up and optimizing their ovulation induction could enhance outcomes
Time frame: 36 hours after ovulation triggering
Number of retrieved oocytes after second ovulation induction in patients with FOP
Time frame: 24 to 36 hours after ovulation triggering
Time interval outcomes between trigger and ovum pickup
Clinique Ovo
Industry
Outcomes From Secondary Ovulation Induction Following Failed Oocyte Pick-up IVF Cycles
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05722067
Artificial Oocyte Activation, Genital Diseases
Kaohsiung City, Taiwan
View Trial DetailsNCT05873725
Genital Diseases, IVF
Montreal, Quebec, Canada
View Trial DetailsNCT07174817
Body Weight, Body Weight Changes
Beijing, Beijing Municipality, China
View Trial DetailsNCT06369415
Development, Child, Genital Diseases
Ho Chi Minh City, Tan Binh, Vietnam
View Trial Details